ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Widening the therapeutic index for pediatric medulloblastoma by targeting BET proteins | Harvard University / Kristopher Sarosiek, Ph.D. | R Accelerated Award Grants | 2024 | Massachusetts |
Dissecting the role and mechanism of MLLT10 fusion proteins to treat pediatric leukemia | The Trustees of the University of Pennsylvania / Kathy Fange Liu, Ph.D. | R Accelerated Award Grants | 2024 | Pennsylvania |
Uridine is a Targetable Metabolic Dependency in Acute Lymphoblastic Leukemia | Board of Trustees of the Leland Stanford Junior University / Kara Davis, D.O. | R Accelerated Award Grants | 2024 | California |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic | Baylor College of Medicine / Robin Parihar, MD/PhD | Reach Grants | 2024 | Texas |
Translating sarcoma antigen-directed co-stimulatory NK cells to the clinic | Baylor College of Medicine / Robin Parihar | Reach Grants | 2024 | Texas |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics | Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD | Reach Grants | 2024 | New York |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma | Children’s Hospital of Philadelphia / John Maris, MD | Reach Grants | 2024 | Pennsylvania |
Overcoming Menin-inhibitor resistance | Children’s Hospital of Philadelphia / Kathrin Bernt, MD | Reach Grants | 2024 | Pennsylvania |
Targeting protein synthesis in pediatric acute myeloid leukemia | Cincinnati Children's Hospital Medical Center / Courtney Jones, PhD | 'A' Award Grants | 2024 | Ohio |
Uncovering new approaches to target FOXR2 in pediatric cancers | Children’s Hospital Los Angeles / Jessica Tsai, MD/PhD | 'A' Award Grants | 2024 | California |